Atossa Therapeutics Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances STRRP Q1 2026 Earnings Preferred Stock Reports Sharp EPS Miss Yet Shares Gain FTAIM Q1 2026 Earnings EPS Falls Short of Estimates Preferred Shares Unchanged HTGC Q1 2026 Earnings EPS Misses Estimates by a Narrow Margin Odyssey Marine Exploration Inc OMEX Q1 2016 Earnings Surprise Profit as Revenue Remains Elusive BEP Q1 2026 Earnings Significant EPS Miss Despite Slight Stock Gains